Yeh Steven, Cebulla Colleen M, Witherspoon S Robert, Emerson Geoffrey G, Emerson M Vaughn, Suhler Eric B, Albini Thomas A, Flaxel Christina J
Department of Ophthalmology, Casey Eye Institute, Oregon Health Sciences University, Portland, Oregon 97239, USA.
Arch Ophthalmol. 2009 Sep;127(9):1218-21. doi: 10.1001/archophthalmol.2009.203.
Three patients with chronic, noninfectious uveitis requiring immunosuppressive therapy underwent fluocinolone acetonide (FA) implant exchange complicated by dissociation of the medication reservoir from its anchoring strut. In 2 patients, the medication reservoir descended into the vitreous cavity and required pars plana vitrectomy with intraocular foreign body removal techniques for its retrieval. The use of viscoelastic or perfluorocarbon to elevate the device was helpful in the safe removal of the FA implant device. Surgeons performing FA implant exchange should be aware of this potential complication and anticipate the possible need for vitreoretinal instrumentation and personnel. Patients undergoing FA explantation or exchange should be counseled regarding this potential complication prior to surgery.
三名需要免疫抑制治疗的慢性非感染性葡萄膜炎患者接受了醋酸氟轻松(FA)植入物置换,出现了药物储存器与其固定支柱分离的并发症。在2名患者中,药物储存器落入玻璃体腔,需要采用玻璃体切割联合眼内异物取出技术进行取出。使用粘弹性物质或全氟碳化合物提升装置有助于安全取出FA植入装置。进行FA植入物置换的外科医生应意识到这种潜在并发症,并预计可能需要玻璃体视网膜手术器械和人员。在手术前,应对接受FA取出或置换的患者告知这种潜在并发症。